Do These New Hires Reveal Apple’s Secret iWatch Plans?
Although Apple (NASDAQ:AAPL) is notoriously secretive about upcoming products that it is developing, its company acquisitions and specialist hires can sometimes offer clues about what the California-based company has up its sleeve. As first reported by 9to5Mac’s Mark Gurman, Apple recently hired Nancy Dougherty and Ravi Narasimhan, two medical-sensor experts with wearable technology experience.
According to a Google (NASDAQ:GOOG) cache of her LinkedIn (NYSE:LNKD) profile page, Dougherty last worked as the Hardware Lead for Sano Intelligence, a startup that is developing a wearable device that can “continuously monitor blood chemistry via microneedles in the interstitial fluid.” Dougherty also previously worked for Proteus Digital Health where she helped to develop “an FDA regulated Class II medical device; a Bluetooth-enabled electronic ‘Band-Aid’ that monitors heart rate, respiration, motion, and temperature, as well as detects technologically enabled ‘Smart Pills’ that are ingested and activated in the stomach.”
According to Ravi Narasimhan’s LinkedIn profile page, he was hired away from Vital Connect, a biosensor technology company. At his previous job, Narasimhan oversaw the company’s research and development on biosensor technology for “remote physiological monitoring with wearable medical devices.” Both hires suggest that Apple may be developing an iWatch, or other wearable tech device, with health-monitoring features.